ELISA News and Research

RSS

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

In an article published in the open-access journal Advance Engineering, a multinational team of researchers reported the selection and characterization of 3 potent SARS-CoV-2 antibodies - S-E6, S-B8, and S-D4 - from a pre-COVID-19 human combinatorial antibody library that was established 20 years ago.

3 Nov 2021

Trends in SARS-CoV-2 seroprevalence in Massachusetts

A new study reported findings from a retrospective, de-identified and systematic survey of SARS-CoV-2 seroprevalence among childbearing women in Massachusetts.

2 Nov 2021

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

The researchers investigated the neutralizing activity of turmeric root extract, curcumin-containing capsules, and pure curcumin against SARS-CoV-2.

1 Nov 2021

New Canadian serology solution for SARS-CoV-2 infections and vaccination

A new study developed a “Made-in-Canada” solution for enabling scalable and reproducible SARS-CoV-2 serology.

31 Oct 2021

Study of SARS-CoV-2 antibody seroprevalence among domestic cats

Researchers from the University of Veterinary Medicine Hannover have been investigating the spread of the disease in domestic cats in Europe.

27 Oct 2021

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Israeli researchers evaluate the antibody response in ICPs to assess antibody-mediated immunity following vaccination with the Pfizer-BioNTech vaccine.

26 Oct 2021

Blood pressure drug increases SARS-CoV-2 receptors in transmission and pathogenesis associated tissues

A new study aimed to determine whether ACE2 targeting drugs change the tissue levels of ACE2 in healthy mice.

25 Oct 2021

A comparison between Pfizer/BioNTech's and Sinopharm's SARS-CoV-2 vaccines

Researchers compare antibody titers elicited the Pfizer‐BioNTech mRNA and the classic inactivated virus Sinopharm vaccines.

24 Oct 2021

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.

22 Oct 2021

New online tool effective in supporting smoke and tobacco free policies on college campuses

A unique study published today in the Oxford University Press journal Nicotine & Tobacco Research looks at the impact of a new online reporting tool in shaping college campus attitudes and behaviors about smoke and tobacco free (STF) policies.

21 Oct 2021

New research on phagocytosis and SARS-CoV-2's spike protein

A new study showed that convalescent patient plasma and monoclonal anti-spike antibodies were able to induce phagocytosis at high antibody concentrations.

20 Oct 2021

Microscopy-based high content platform for SARS-CoV-2 serological screening

A new study published on the medRxiv* preprint server used automated high content immunofluorescence microscopy (AHCIM) to assess the viability of such an approach to detect humoral immune responses against SARS-CoV-2 proteins.

20 Oct 2021

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

In a recent study published in the journal PLOS Pathogens, scientists showed that nasal administration of a single-domain antibody (VHH), named K-874A, brought about inhibition of SARS-CoV-2 titers in infected lungs of Syrian hamsters.

19 Oct 2021

SARS-CoV-2 antibodies detected in breast milk of vaccinated mothers

Now, a new medRxiv* preprint study finds mothers vaccinated either one of the messenger RNA (mRNA) vaccines transferred neutralizing antibodies and cytokines, including interferon-gamma (IFNγ), to a breastfeeding child. Additionally, the humoral response in breastmilk was effective in neutralizing four variants of concern.

18 Oct 2021

Does vitamin D deficiency increase the risk of SARS-CoV-2 infections?

A recent study posted to the medRxiv* preprint server attempted to understand the relationship between vitamin D levels and COVID-19 by studying a population of UK healthcare workers who exhibited symptoms for COVID-19.

17 Oct 2021

Serologic testing algorithm to detect disparities in SARS-CoV-2 infection prevalence and vaccination uptake

A new study recently published on the medRxiv* preprint server demonstrates the use of a serological testing algorithm for identifying disparities in infection rates and vaccine uptake amongst the study population to enable public health interventions.

17 Oct 2021

Advancing ethical recombinant antibody research with the customer in mind

In this interview, News-Medical speaks to Dr. Tillmann Ziegert, Managing Director at Biorbyt Ltd, about the balance between enhancing ethical research opportunities and keeping customers at center stage.

From Biorbyt 15 Oct 2021

Research finds different antibody responses following COVID vaccination and natural infection

A new study published in the journal Nature attempted to investigate memory B cell evolution 5 months after vaccination with mRNA vaccines such as Moderna (mRNA-1273) or Pfizer-BioNTech (BNT162b2) in SARS-CoV-2 naïve individuals. The study explored various aspects of memory B cell antibody response like neutralizing response, affinity, epitope targeting, and neutralizing breadth.

10 Oct 2021

Inactivated polio vaccine induces antibodies that block SARS-CoV-2 RNA synthesis

A new study introduces the possibility that the inactivated polio vaccine can elicit antibodies that inhibit SARS-CoV-2 nucleic acid synthesis.

10 Oct 2021

Phase I clinical trial of two Cuban recombinant protein COVID-19 vaccines

The results of Phase I clinical trials for two new COVID-19 vaccine candidates based on recombinant RDB proteins are reported.

10 Oct 2021

ELISA News and Research

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

Trends in SARS-CoV-2 seroprevalence in Massachusetts

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

New Canadian serology solution for SARS-CoV-2 infections and vaccination

Study of SARS-CoV-2 antibody seroprevalence among domestic cats

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Blood pressure drug increases SARS-CoV-2 receptors in transmission and pathogenesis associated tissues

A comparison between Pfizer/BioNTech's and Sinopharm's SARS-CoV-2 vaccines

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

New online tool effective in supporting smoke and tobacco free policies on college campuses

New research on phagocytosis and SARS-CoV-2's spike protein

Microscopy-based high content platform for SARS-CoV-2 serological screening

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

SARS-CoV-2 antibodies detected in breast milk of vaccinated mothers

Does vitamin D deficiency increase the risk of SARS-CoV-2 infections?

Serologic testing algorithm to detect disparities in SARS-CoV-2 infection prevalence and vaccination uptake

Advancing ethical recombinant antibody research with the customer in mind

Research finds different antibody responses following COVID vaccination and natural infection

Inactivated polio vaccine induces antibodies that block SARS-CoV-2 RNA synthesis

Phase I clinical trial of two Cuban recombinant protein COVID-19 vaccines

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News